Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, et al
PP analysis (32 participants in the semaglutide group and 25 participants in the placebo group) showed greater percentage change in adjusted body weight in the semaglutide group compared to the placebo group (mean (s.e.), 18.5% (2.1) versus 1.10 (2.2), respectively) with an adjusted mean difference of 19.6% (95% CI 15.6 to 23.5
When in doubt, contact PlexusDx or your prescribing provider rather than risk using compromised medication
We see much greater success when lifestyle changes are part of the plan." "GLP-1 medications can help make those goals achievable, but the real magic happens when patients commit to their health journey." Anthony Bashall, MD, Cardiologist, Franciscan Physician Network This philosophy is at the heart of TrimRXs weight loss program
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven efficacy and safety in randomized clinical trials and observational real-life studies